Syros Pharmaceuticals
Syros Pharmaceuticals Logo
About Syros Pharmaceuticals
Syros Pharmaceuticals Inc is a biopharmaceutical company focused on developing gene control medicines for the treatment of cancer and immune-mediated diseases. Its lead product candidates include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, SY-2101 for acute promyelocytic leukemia, and SY-5609 for advanced solid tumors. The company is building a pipeline of therapies targeting hematologic malignancies and other serious diseases, and conducts business worldwide.
Address
35 CambridgePark Drive, 4th Floor
Cambridge, 02140
United States
Year founded
2011
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
